JN International Medical Corporation in Omaha, Nebraska has developed a vaccine against Stroke. While the repeated animal studies suggest the vaccine works in pigs and their anatomy is closer to human. Strokes begin when inflammation occurs on a molecular level in blood vessels as part of a response by the immune system. During a 5 year long study, the pigs that received treatment with the vaccine had fewer strokes caused by blood clots than those that received Placebo. None of the pigs that had treatment suffered from a hemorrhagic stroke, in which blood vessels rupture and memory loss. Much more study will be needed before the vaccine can be tested in humans. During suggests that the first patients to test should be those with an exceptionally high risk of brain damage from a stroke because they have inoperable brain aneurysms -- small blood vessels that balloon out and threaten to burst. Full scale Phase-1 study is proposed to be conducted in 2009-2010 in the United States. The vaccine technology is filed for patent with United States Patent Office and in 136 PCT countries. The stroke vaccine development technology can be read from web page of World Intellectual Property Organization (WIPO) http://www.wipo.int/pctdb/en/wo.jsp?WO=2008121146 (PRWeb Feb 23, 2009)
Read the full story at http://www.prweb.com/releases/2009/02/prweb2140534.htm
Read More...
[Source: PRWeb: Lifestyle Health and Fitness]
No comments:
Post a Comment